Manufacturing news briefs – stories you might have missed

CSL finalises purchase of Vifor Pharma Australian biotech and vaccine manufacturer CSL has finalised all regulatory clearances for its $17.2 billion all cash takeover of a complementary healthcare business, Swiss pharmaceutical manufacturer Vifor. Completion of the acquisition, announced in December will now take place by 9 August. CSL CEO Paul Perreault said the Vifor business…